APA (7th ed.) Citation

Visser, P. J., Reus, L. M., Gobom, J., Jansen, I., Dicks, E., van der Lee, S. J., . . . Tijms, B. M. (2022). Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease. Molecular neurodegeneration, 17(1), 37-2. https://doi.org/10.1186/s13024-022-00540-0

Chicago Style (17th ed.) Citation

Visser, Pieter Jelle, et al. "Correction: Cerebrospinal Fluid Tau Levels Are Associated with Abnormal Neuronal Plasticity Markers in Alzheimer’s Disease." Molecular Neurodegeneration 17, no. 1 (2022): 37-2. https://doi.org/10.1186/s13024-022-00540-0.

MLA (9th ed.) Citation

Visser, Pieter Jelle, et al. "Correction: Cerebrospinal Fluid Tau Levels Are Associated with Abnormal Neuronal Plasticity Markers in Alzheimer’s Disease." Molecular Neurodegeneration, vol. 17, no. 1, 2022, pp. 37-2, https://doi.org/10.1186/s13024-022-00540-0.